Orano Med
Yolande Dague is an experienced quality assurance technician currently employed at Orano Med since June 2021, following a substantial tenure at Catalent Pharma Solutions from December 2006 to June 2021 as a quality control technician. Yolande began professional career at Clinique Chenieux Limoges as a sterilization agent from July 2005 to December 2006. Educational qualifications include a Licence in hygiene and safety from IUT de Laval obtained in 2005 and a DUT in biological engineering/biosystems from Université de Limoges completed in 2004.
This person is not in any offices
Orano Med
1 followers
Based on an R&D program started in 2005, Orano Med has developed new processes for producing high-purity lead-212 (Pb-212), a rare radioactive isotope. Lead-212 is currently at the heart of promising projects in nuclear medicine to develop new treatments against cancer. The innovative approach, known as targeted alpha therapy (TAT), recognizes and destroys cancer cells while limiting the impact on nearby healthy cells. Macrocyclics, Inc., an Orano Med company, is the global leader in high performance chelating agent technology, offering a broad range of services and products. For more information please visit www.macrocyclics.com.